Log In
BCIQ
Print this Print this
 

AmBisome, amphotericin B

  Manage Alerts
Collapse Summary General Information
Company Gilead Sciences Inc.
DescriptionUnilamellar liposomal formulation of amphotericin B
Molecular Target Ergosterol
Mechanism of ActionCell membrane destabilization
Therapeutic ModalityMacrocycle

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/10/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today